SHORT MINI FUTURE WARRANT - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 19:27:09 31/05/2024 BST | ||
| 2.204 EUR | -2.56% |
|
| 1 month | +13.03% | ||
| 3 months | +61.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 31/05/24 | 2.204 | -2.56% |
| 30/05/24 | 2.262 | -0.48% |
| 29/05/24 | 2.273 | +1.29% |
| 28/05/24 | 2.244 | +3.94% |
| 27/05/24 | 2.159 | -0.96% |
Real-time BOERSE MUENCHEN
Last update May 31, 2024 at 07:27 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Goldman Sachs |
| WKN | GQ00EE |
| ISIN | DE000GQ00EE2 |
| Date issued | 25/07/2023 |
| Strike | 64.94 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 0.14 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.304 € |
|---|---|
| Lowest since issue | 0.228 € |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09
USD
Average target price
53.19
USD
Spread / Average Target
+29.46%
- Stock Market
- Certificates
- Certificat
